NDC 42961-112 – Xpect Cold Relief
Guaifenesin 200 mg/1; Acetaminophen 325 mg/1; Phenylephrine Hydrochloride 5 mg/1 · Tablet · Oral
Product NDC42961-112
Product details
- Brand name
- Xpect Cold Relief
- Generic name
- Acetaminophen Guaifenesein Phenylephrine HCl
- Labeler
- Cintas Corporation
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M013
- Marketed since
- March 29, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Expectorant; alpha-1 Adrenergic Agonist
Active ingredients
- Guaifenesin 200 mg/1
- Acetaminophen 325 mg/1
- Phenylephrine Hydrochloride 5 mg/1
Uses, dosage, side effects and warnings for Xpect Cold Relief →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 42961-112-13 | 25 PACKET in 1 BAG (42961-112-13) / 2 TABLET in 1 PACKET (42961-112-10) | Sep 23, 2025 |
| 42961-112-14 | 40 PACKET in 1 BOX (42961-112-14) / 2 TABLET in 1 PACKET (42961-112-10) | Sep 23, 2025 |
Recalls mentioning this NDC
- D-0483-2022 Feb 9, 2022 · Class II
cGMP deviations